Back to Search
ROBERT SIKES, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1366828360Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
18105-40(WI)
Research & Publications (20)
Quantitative modeling and analysis of the transforming growth factor beta signaling pathway.
PMID 19254534·Biophys J·2009
8-other
Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.
PMID 19223557·Cancer Res·2009
7-preclinical
Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation.
PMID 19421879·Clin Exp Metastasis·2009
7-preclinical
Distribution and properties of visceral nociceptive neurons in rabbit cingulate cortex.
PMID 18022321·Pain·2008
7-preclinical
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha.
PMID 18561328·J Cell Biochem·2008
8-other
Norepinephrinergic afferents and cytology of the macaque monkey midline, mediodorsal, and intralaminar thalamic nuclei.
PMID 18317800·Brain Struct Funct·2008
7-preclinical
Variation in digestive efficiency of captive North American river otters (Lontra canadensis) on various diets.
PMID 19360560·Zoo Biol·2007
8-other
Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression model.
PMID 17492783·J Cell Physiol·2007
8-other
Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells.
PMID 17440078·Cancer Res·2007
7-preclinical
Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
PMID 16869958·BMC Cancer·2006
8-other
Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
PMID 16500022·Cancer Lett·2006
8-other
Cancer cells homing to bone: the significance of chemotaxis and cell adhesion.
PMID 15043197·Cancer Treat Res·2004
6-review
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.
PMID 15574769·Cancer Res·2004
8-other
Thalidomide and analogues: current proposed mechanisms and therapeutic usage.
PMID 15279692·Clin Prostate Cancer·2004
6-review
Cellular interactions in the tropism of prostate cancer to bone.
PMID 15122581·Int J Cancer·2004
8-other
Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer.
PMID 14711377·Reprod Biol Endocrinol·2004
6-review
Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers.
PMID 15040863·Clin Prostate Cancer·2003
6-review
Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate.
PMID 14659016·Genome Biol·2003
7-preclinical
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3.
PMID 14617788·Mol Cancer Ther·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4301 W WISCONSIN AVE, SUITE 42 (T-0238)
APPLETON, WI 54913 - Phone
- (920) 243-7877
Quick Facts
- NPI
- 1366828360
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile